GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (LSE:AVCT) » Definitions » Other Operating Expense

Avacta Group (LSE:AVCT) Other Operating Expense : £6.58 Mil (TTM As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Avacta Group Other Operating Expense?

Avacta Group's Other Operating Expense for the six months ended in Dec. 2023 was £3.31 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was £6.58 Mil.

Avacta Group's quarterly Other Operating Expense declined from Dec. 2022 (£6.86 Mil) to Jun. 2023 (£3.27 Mil) but then increased from Jun. 2023 (£3.27 Mil) to Dec. 2023 (£3.31 Mil).

Avacta Group's annual Other Operating Expense increased from Dec. 2021 (£9.48 Mil) to Dec. 2022 (£10.44 Mil) but then declined from Dec. 2022 (£10.44 Mil) to Dec. 2023 (£6.58 Mil).


Avacta Group Other Operating Expense Historical Data

The historical data trend for Avacta Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group Other Operating Expense Chart

Avacta Group Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.27 4.96 9.48 10.44 6.58

Avacta Group Semi-Annual Data
Jul13 Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.03 3.58 6.86 3.27 3.31

Avacta Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £6.58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avacta Group Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Avacta Group's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Avacta Group (LSE:AVCT) Business Description

Traded in Other Exchanges
Address
Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Avacta Group (LSE:AVCT) Headlines

No Headlines